No I’m not
I just want Anp to succeed
But you keep putting our Board down.
You see Sam
Atl1103 does not need a Tox study done in the US for Acromeglia
However
Now that Ionis has dropped Acromeglia Anp can move into another trial ( go it alone or Partner)
CG has stated that DMD is our priority so until we get more $$ into the Bank I guess Anp will Partner? ( or go it alone at a later date )
You say “ didn’t exactly see eye to eye”..There lies your problem.. You don’t know what goes on behind closed doors… and he has the credentials to take us all the way to commercialisation… do you ??
No I’m notI just want Anp to succeed But you keep putting our...
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.6¢ |
Change
-0.004(5.00%) |
Mkt cap ! $68.51M | |||
| Open | High | Low | Value | Volume |
| 8.0¢ | 8.0¢ | 7.6¢ | $201.6K | 2.545M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 146314 | 7.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.3¢ | 106165 | 2 |
View Market Depth
| Last trade - 16.10pm 09/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.7¢ |
Change
-0.004 ( 3.75 %) |
||||
| Open | High | Low | Volume | ||
| 7.9¢ | 8.0¢ | 7.7¢ | 79316 | ||
| Last updated 15.57pm 09/05/2024 ? | |||||
| PER (ASX) Chart |